In this study, we used Drosophila melanogaster to study the effects of DR (namely, protein restriction), an oncogene-specific pharmacological intervention and DR combined with the pharmacological intervention on tumor development and organismal survival in a stem cell-derived tumor model induced by overexpression of a constitutively active form of EGFR (EgfrCA). The gene discussed is EGFR; the disease is neoplasm.